Cancer treatment medications; prohibit health care providers from using the buy and bill process for purchasing and administering.

Plain English Breakdown

The bill's status as 'Did Not Pass' means it will not be enforced or have an effective date.

Stop Buying Cancer Drugs First

This bill stops health care providers from buying cancer treatment drugs using the buy and bill process.

What This Bill Does

• Defines 'buy and bill process' as a method where health care providers purchase specialty medications, store them in-house, administer to patients, and then seek reimbursement from insurance companies.
• Prohibits health care providers from purchasing and administering cancer treatment drugs using the buy and bill process.

Who It Names or Affects

• Health care providers who treat cancer patients
• Patients receiving cancer treatments

Terms To Know

buy and bill process

A reimbursement model where health care providers purchase specialty medications, store them in-house, administer to patients, and seek reimbursement from insurance companies.

Limits and Unknowns

• The bill did not pass and will not become a law.
• It only affects cancer treatment drugs, not other types of medicines.

Official Summary Text

Cancer treatment medications; prohibit health care providers from using the buy and bill process for purchasing and administering.

Current Bill Text

H. B. No. 1336 *HR26/R1771* ~ OFFICIAL ~ G1/2
26/HR26/R1771
PAGE 1 (RF\KW)
ST: Cancer treatment medications; prohibit
health care providers from using the buy and
bill process for purchasing and administering.
To: Public Health and Human
Services
MISSISSIPPI LEGISLATURE REGULAR SESSION 2026

By: Representative Arnold

HOUSE BILL NO. 1336

AN ACT TO PROHIBIT HEALTH CARE PROVIDERS FROM USING THE BUY 1
AND BILL PROCESS FOR PURCHASING AND ADMINISTERING MEDICATIONS USED 2
FOR TREATMENT OF CANCER; AND FOR RELATED PURPOSES. 3
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MISSISSIPPI: 4
SECTION 1. (1) As used in this section, the term "buy and 5
bill process" means a reimbursement model in which a health care 6
provider purchases specialty medications from a specialty 7
distributor, stores the medications in-house to have an inventory 8
of the medications, administers the medications to patients in 9
their office or in a clinic setting, and then submits a claim for 10
the administered medication for reimbursement to a third-party 11
payer. 12
(2) Health care providers shall not use the buy and bill 13
process for purchasing and administering medications used for 14
treatment of cancer. 15
SECTION 2. This act shall take effect and be in force from 16
and after July 1, 2026. 17